Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | PPID | Q08752 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 3/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.41 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6513762 | 0.89 | LMNA (0.42) | TDP1SMN1; SMN2ALOX5KDM4EALDH1A1 | |
| SCHEMBL6522447 | 0.87 | TDP1 (0.44) | TDP1SMN1; SMN2ALOX5AKR1B10AKR1B1 | |
| SCHEMBL8812410 | 0.86 | TDP1 (0.54) | TDP1SMN1; SMN2ALOX5AKR1B10AKR1B1 | |
| SCHEMBL6518132 | 0.86 | TDP1 (0.45) | TDP1SMN1; SMN2ALOX5KDM4EALDH1A1 | |
| SCHEMBL27843168 | 0.83 | TDP1 (0.58) | ABCB1TDP1SMN1; SMN2PPIDLTA4H | |
| SCHEMBL6518651 | 0.81 | ALDH1A1 (0.43) | ABCB1TDP1SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL6523578 | 0.81 | ALDH1A1 (0.43) | ABCB1TDP1SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL6513722 | 0.81 | SMN1; SMN2 (0.43) | TDP1SMN1; SMN2ALDH1A1 | |
| SCHEMBL15122553 | 0.80 | MEN1 (0.49) | TDP1SMN1; SMN2ALOX5KDM4EALDH1A1 | |
| SCHEMBL6514662 | 0.80 | MGAM (0.54) | NLRP3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | ABCB1 2481/4885TDP1 1789/4885NLRP3 3682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.